Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Roivant Sciences Ltd. (ROIV) had Operating Cash Flow per Share of $-1.08 for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$8.26M |
|
$-299.77M |
|
$1.28M |
|
$6.97M |
|
$523.33M |
|
$-515.07M |
|
$250.49M |
|
$-264.58M |
|
$-369.62M |
|
$-397.91M |
|
$-397.91M |
|
$-397.91M |
|
$-450.02M |
|
$-515.07M |
|
$-511.72M |
|
693.87M |
|
693.87M |
|
$-0.43 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$5.17B |
|
$11.99M |
|
$541.30M |
|
$5.71B |
|
$281.24M |
|
-- |
|
$135.03M |
|
$416.27M |
|
$5.29B |
|
$5.29B |
|
$5.29B |
|
720.35M |
|
| Cash Flow Statement Financials | |
$-750.35M |
|
$-682.33M |
|
$134.24M |
|
$2.73B |
|
$1.43B |
|
$-1.29B |
|
$346.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
84.44% |
|
-6235.69% |
|
-6235.69% |
|
-6195.16% |
|
-3203.12% |
|
-3629.19% |
|
$-758.56M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.03M |
|
-7.52% |
|
-7.52% |
|
-6.97% |
|
-7.52% |
|
$7.35 |
|
$-1.09 |
|
|
Operating Cash Flow per Share |
$-1.08 |